BIPOL LEAD MODEL 300 300-20

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2020-03-31 for BIPOL LEAD MODEL 300 300-20 manufactured by Cyberonics - Houston.

Event Text Entries

[188030518] It was reported that the patient's vns showed high lead impedance during pre-op diagnostics for the patient's prophylactic generator replacement. The high impedance was seen with the new generator as well. No known lead revision has occurred to date. No additional relevant information has been received to date.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1644487-2020-00535
MDR Report Key9904023
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2020-03-31
Date of Report2020-03-31
Date of Event2020-03-06
Date Mfgr Received2020-03-06
Device Manufacturer Date1999-09-23
Date Added to Maude2020-03-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS. RACHEL KOHN
Manufacturer Street100 CYBERONICS BLVD SUITE 600
Manufacturer CityHOUSTON TX 77058
Manufacturer CountryUS
Manufacturer Postal77058
Manufacturer Phone2812287200
Manufacturer G1CYBERONICS - HOUSTON
Manufacturer Street100 CYBERONICS BLVD SUITE 600
Manufacturer CityHOUSTON TX 77058
Manufacturer CountryUS
Manufacturer Postal Code77058
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIPOL LEAD MODEL 300
Generic NameLEAD
Product CodeLYJ
Date Received2020-03-31
Model Number300-20
Lot Number29042C
Device Expiration Date2001-09-30
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCYBERONICS - HOUSTON
Manufacturer Address100 CYBERONICS BLVD HOUSTON TX 77058 US 77058


Patients

Patient NumberTreatmentOutcomeDate
10 2020-03-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.